Sprint Bioscience AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2024 * | 118M 10.87M 0 | Sales 2025 * | 199M 18.32M 0 | Capitalization | 92.02M 8.47M 0 |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.03 x |
Net cash position 2024 * | 88.2M 8.12M 0 | Net cash position 2025 * | - 0 - | EV / Sales 2025 * | 0.46 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.2% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Emilsson
CEO | Chief Executive Officer | 40 | 23-09-30 |
Martin Andersson
FOU | Founder | 53 | 08-12-31 |
Director of Finance/CFO | 51 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 19-12-31 | |
Chairman | 56 | 20-12-31 | |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |